Elsevier

Thrombosis Research

Volume 51, Issue 3, 1 August 1988, Pages 241-249
Thrombosis Research

Paper
Behavior of protein S during long-term oral anticoagulant therapy

https://doi.org/10.1016/0049-3848(88)90101-6Get rights and content

Abstract

It has recently been reported that a natural anticoagulant, protein S (PS), is depressed during oral anticoagulation. Since more detailed information is required from the clinical standpoint, we measured plasma levels of PS [both total and free (not complexed) PS antigen], C4b-binding protein (C4bp) and other vitamin K-dependent proteins (factors II, VII, IX, X and protein C) in 60 plasma samples from patients on long-term oral anticoagulant therapy with warfarin. Together with the reduction of other vitamin K-dependent plasma proteins, PS decreased during warfarin treatment, being dependent on the intensity of the therapy. A considerable variation in plasma PS levels was also observed among individuals with a similar intensity of anticoagulation. Plasma concentration of C4bp was closely correlated with total PS level, and free PS/total PS ratio was independent of thrombotest values. These findings indicate that long-term oral anticoagulant therapy results in the suppression of the synthesis of PS, and that its reduction is on the whole balanced with C4bp and vitamin K-dependent coagulation factors. It was suggested that the metabolism of C4bp might be regulated by the plasma PS level, although this hypothesis needs further exploration.

References (26)

  • F.J. Walker

    Protein S and the regulation of activated protein C

    Semin. Thromb. Hemostas.

    (1984)
  • B. Dahlbäck et al.

    High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein

  • B. Dahlbäck

    Purification of human C4b-binding protein and formation of its complex with vitamin K-dependent protein S

    Biochem. J.

    (1983)
  • Cited by (15)

    • Complement activation and plasma levels of C4b-binding protein in critical limb ischemia patients

      2009, Journal of Vascular Surgery
      Citation Excerpt :

      In our study, both C4BPtot and C4BPβ levels were significantly lower in CLI patients treated with the anticoagulant warfarin in comparison to patients without such treatment. A diminution in C4BP plasma concentration was already found in patients with inherited protein S deficiency;33 and the concentration of protein S itself is known to likewise decrease during warfarin therapy.34 The molecular mechanisms for the correlation between decreased protein S and decreased C4BP levels during warfarin treatment still have to be elucidated, but our finding implies that the level of protein S influences the synthesis of C4BPtot and C4BPβ by hepatocytes.

    • Hypercoagulability and thrombosis

      1994, Medical Clinics of North America
    • Hypercoagulability and thrombosis

      1992, Hematology/Oncology Clinics of North America
    View all citing articles on Scopus
    View full text